GAFFX | OTFCX | GAFFX / OTFCX | |
Total Expense Ratio | 0.30 | 1.71 | 18% |
Annual Report Gross Expense Ratio | 0.30 | 1.71 | 18% |
Fund Existence | 8 years | 32 years | - |
Gain YTD | 5.197 | -0.954 | -544% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 1000 | 100,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 306B | 5.61B | 5,457% |
Annual Yield % from dividends | 0.65 | 0.00 | - |
Returns for 1 year | 7.65 | 1.22 | 628% |
Returns for 3 years | 54.61 | 60.89 | 90% |
Returns for 5 years | 51.03 | 8.21 | 621% |
Returns for 10 years | N/A | -19.12 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ECHSX | 12.96 | -0.14 | -1.07% |
Eaton Vance Worldwide Health Sci C | |||
CGVFX | 25.68 | -0.33 | -1.27% |
American Funds Global Insight 529-F-1 | |||
IAVGX | 19.77 | -0.26 | -1.30% |
Voya Growth and Income Port A | |||
HSLSX | 38.82 | -0.64 | -1.62% |
Hartford Small Cap Growth R4 | |||
SEKAX | 19.75 | -0.39 | -1.94% |
DWS Emerging Markets Equity A |